Heron Therapeutics Inc. (NASDAQ:HRTX) issued its quarterly earnings data on Tuesday. The biotechnology company reported ($1.24) EPS for the …
Heron Therapeutics Inc. (NASDAQ:HRTX) issued its quarterly earnings data on Tuesday. The biotechnology company reported ($1.24) EPS for the …
0 Comments